patient safety
Most Effective Contribution to Patient Safety

Thanks to the recently published National Patient Safety strategy, a renewed focus on the principle of continuous safety improvement, underpinned by a safety culture and effective safety system, has swept across the NHS.  At the heart of this lies the aim of a zero-avoidable harm environment, which has taken on a whole extra meaning since Covid-19 reached the UK, particularly around infection prevention and control. 

The adoption of new technologies, enhancements in education and training, or complete redesign in working practices all play their part in risk reduction, and partnership working is fundamental to these developments. 

This award will recognise those projects and partnerships that have in some way improved the identification and reduction of risk to patients or helped develop a culture in which incidents are reliably reported, investigated, and learnt from. The partnership may or may not have patient safety as its primary goal, yet demonstrable improvements in patient care and the avoidance of harm are what the judges are looking to recognise in this award. 

Eligibility

  • This award is open to any private or not-for-profit organisation which works in partnership with an NHS organisation 
  • These can be single partnerships or joint working projects, but must demonstrate evidence from the past two years up until the awards deadline date 

Ambition 

  • Detail the context in which the partnership was created, and the wider vision for patient safety and quality of care within the NHS organisation. 
  • How was learning from previous adverse events or near misses utilised to identify the parameters and goals of the partnership?  
  • What targets were developed and what measures were taken to achieve them? 

Outcome 

  • Evidence with quantitative data how safety within the NHS organisation has improved and adverse events have fallen as a direct result of the partnership. This could be in one specific context, or a variety of ways across multiple settings. 
  • Provide testimonial evidence of the effectiveness and impact of the partnership from both NHS staff and patients. 
  • To what extent has the partnership resulted in the delivery of consistently higher quality care? 

Spread 

  • Describe how the business has worked with the NHS to ensure best practice learning surrounding risk reduction and avoidance of harm has been disseminated. 
  • Discuss to what extent best practices or innovations generated by the partnership have been adopted by other NHS departments or organisations within the wider STP/ICS. 
  • Have the best practices or innovations been employed within other partnerships formed by the private sector partner? 

Involvement 

  • Describe how the partnership has contributed to the development of a safety culture  
  • To what extent were frontline clinicians, patients and relatives engaged within the development of new initiatives and improvements? 
  • Judges are particularly looking for evidence that consultation continues to take place between all parties to ensure continuous improvement and innovation, whether the partnership remains in place or has come to an end. 

Value 

  • Describe the value which has been achieved, in terms of efficiency, patient outcomes, and reduction in adverse incidents, over and above what the NHS could have delivered alone.  
  • To what extent has the partnership delivered any additional benefits to patient experience such as reduced waiting times, improved communication, or ease of service access? 
  • Describe, with supporting evidence, any monetary impact of patient safety improvements – has the partnership delivered value for money? 
patient safety
Most Effective Contribution to Patient Safety

To find out more

For entry enquiries, contact Ryan Bessent on 0207 608 9045 or email Ryan.bessent@wilmingtonhealthcare.com